Within hours of the World Health Organization designating Omicron a variant of concern late last month, Moderna issued a press release telling the public it was already working on a vaccine booster that could target the new threat.
Within hours of the World Health Organization designating Omicron a variant of concern late last month, Moderna issued a press release telling the public it was already working on a vaccine booster that could target the new threat.
Researchers at McMaster University in Ontario have been approved to begin human trials on two Canadian-made COVID-19 vaccines that are delivered by inhaled aerosol to target the lungs and upper airways.